← Back to Clinical Trials
Recruiting NCT06129214

NCT06129214 Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06129214
Status Recruiting
Phase —
Sponsor Gangnam Severance Hospital
Condition Osteoarthritis, Knee
Study Type INTERVENTIONAL
Enrollment 78 participants
Start Date 2023-10-16
Primary Completion 2025-10-06

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
PrepectoralSubpectoral

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 78 participants in total. It began in 2023-10-16 with a primary completion date of 2025-10-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Crepitus causing unsatisfied result to patients after posterior stabilized total knee arthroplasty. Recent retrospective study demonstrated removal of hyperplastic synovium in distal quadriceps caused reduce of crepitus. However, this study has limitation of time gap exist between arms, different in observation time and bias caused by retrospective review. Thus aim of this study is that by randomized trial, verified hyperplastic synovium in distal quadriceps causing crepitus. Target enrolled patients in this study are scheduled to perform both total knee arthroplasty. Experimental group is randomized side (right or left) of knee, and control group is other side of knee. Both arms decided by randomized number table. Crepitus measured after 3mo, 6mo, 1year after surgical treatment

Eligibility Criteria

Inclusion Criteria: 1.Patients who scheduled to perform both total knee arthroplasty(TKA) using posteiror crucitate sustain type (PS) Exclusion Criteria: 1. Lost follow up (Including death of patient) 2. Unexpected complication (e.g) Infection, periprosthetic fracture) 3. Patella resurfacing 4. Canceled surgical treatment 5. Refused to enrolled study 6. Too much radiological or physicological variance shown between either knee

Contact & Investigator

Central Contact

Woo Suk Lee

✉ gsirb@yuhs.ac

📞 82-2-2019-4601

Frequently Asked Questions

Who can join the NCT06129214 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Osteoarthritis, Knee. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06129214 currently recruiting?

Yes, NCT06129214 is actively recruiting participants. Contact the research team at gsirb@yuhs.ac for enrollment information.

Where is the NCT06129214 trial being conducted?

This trial is being conducted at Seoul, South Korea.

Who is sponsoring the NCT06129214 clinical trial?

NCT06129214 is sponsored by Gangnam Severance Hospital. The trial plans to enroll 78 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology